Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Phenomix gets $32mm funding commitment; increased by $3.5mm

Executive Summary

Forward genetics start-up, Phenomix Corp. (focuses on rapid target identification and validation) secured $12mm in a Series A financing round co-led by Sofinnova Ventures and Alta Partners, and also included Bay City Capital, CM Capital Investments, CMEA Ventures, Novartis BioVenture Fund, Rothschild Bioscience Managers, Versant Ventures, and other investors. The company has an option to draw on an additional $20mm as needed.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies